Literature DB >> 32274800

Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.

Jaime L Lopes1, Guilherme S Lopes2, Elizabeth A L Enninga3, Hutton M Kearney1, Nicole L Hoppman1, Ross A Rowsey1.   

Abstract

OBJECTIVE: We aimed to test for an association between the amount of circulating fetal cell-free DNA and trisomy, and whether NIPS failure due to low fetal fraction indicates trisomy risk.
METHOD: Maternal BMI, maternal age, fetal sex, gestational age, fetal cfDNA fraction, and NIPS results was collected on 2374 pregnancies. Additional clinical information was available for 1180 research consented patients. We investigated associations between fetal fraction and available variables and determined the success rate of repeat NIPS testing.
RESULTS: Fetal trisomy was marginally associated with decreased fetal fraction (P = .067). However, the proportions of trisomy events were not significantly increased in women who had failed NIPS due to low fetal fraction (<4%) (OR = 1.37 [0.3-7.4]; P = .714). 66% of repeated NIPS after a second blood draw were successful.
CONCLUSION: Failure to meet the clinical cutoff of 4% fetal fraction established for NIPS accuracy did not suggest increased risk for trisomy in our cohort. Because repeat testing was successful in the majority of cases and most failures were explained by high BMI and low gestational age, a redraw may be an appropriate next step before invasive screening due to concerns for trisomic pregnancies.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32274800      PMCID: PMC7377435          DOI: 10.1002/pd.5693

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  19 in total

1.  Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report.

Authors:  E Flori; B Doray; E Gautier; M Kohler; P Ernault; J Flori; J M Costa
Journal:  Hum Reprod       Date:  2004-01-29       Impact factor: 6.918

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.

Authors:  Mary E Norton; Herb Brar; Jonathan Weiss; Ardeshir Karimi; Louise C Laurent; Aaron B Caughey; M Hellen Rodriguez; John Williams; Michael E Mitchell; Charles D Adair; Hanmin Lee; Bo Jacobsson; Mark W Tomlinson; Dick Oepkes; Desiree Hollemon; Andrew B Sparks; Arnold Oliphant; Ken Song
Journal:  Am J Obstet Gynecol       Date:  2012-06-01       Impact factor: 8.661

Review 4.  Human aneuploidy: incidence, origin, and etiology.

Authors:  T Hassold; M Abruzzo; K Adkins; D Griffin; M Merrill; E Millie; D Saker; J Shen; M Zaragoza
Journal:  Environ Mol Mutagen       Date:  1996       Impact factor: 3.216

5.  Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts.

Authors:  Sung K Kim; Gregory Hannum; Jennifer Geis; John Tynan; Grant Hogg; Chen Zhao; Taylor J Jensen; Amin R Mazloom; Paul Oeth; Mathias Ehrich; Dirk van den Boom; Cosmin Deciu
Journal:  Prenat Diagn       Date:  2015-06-03       Impact factor: 3.050

6.  Turner syndrome: New insights from prenatal genomics and transcriptomics.

Authors:  Diana W Bianchi
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-01-31       Impact factor: 3.908

7.  Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy.

Authors:  Kristin D Gerson; Samantha Truong; Miriam J Haviland; Barbara M O'Brien; Michele R Hacker; Melissa H Spiel
Journal:  Pregnancy Hypertens       Date:  2019-04-13       Impact factor: 2.494

Review 8.  Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis.

Authors:  Sian Taylor-Phillips; Karoline Freeman; Julia Geppert; Adeola Agbebiyi; Olalekan A Uthman; Jason Madan; Angus Clarke; Siobhan Quenby; Aileen Clarke
Journal:  BMJ Open       Date:  2016-01-18       Impact factor: 2.692

9.  Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.

Authors:  Anthony R Gregg; Brian G Skotko; Judith L Benkendorf; Kristin G Monaghan; Komal Bajaj; Robert G Best; Susan Klugman; Michael S Watson
Journal:  Genet Med       Date:  2016-07-28       Impact factor: 8.822

10.  Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.

Authors:  T McKanna; A Ryan; S Krinshpun; S Kareht; K Marchand; C Grabarits; M Ali; A McElheny; K Gardiner; K LeChien; M Hsu; D Saltzman; M Stosic; K Martin; P Benn
Journal:  Ultrasound Obstet Gynecol       Date:  2018-11-26       Impact factor: 7.299

View more
  4 in total

1.  Lipid Metabolism Affects Fetal Fraction and Screen Failures in Non-invasive Prenatal Testing.

Authors:  Jun Cao; Longwei Qiao; Jieyu Jin; Sheng Zhang; Ping Chen; Haoyu Tang; Zheng Yu; Jingye Shi; Ting Wang; Yuting Liang
Journal:  Front Med (Lausanne)       Date:  2022-01-12

Review 2.  Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review.

Authors:  Cechuan Deng; Shanling Liu
Journal:  Front Pediatr       Date:  2022-01-27       Impact factor: 3.418

3.  Follow-up in Patients With Non-invasive Prenatal Screening Failures: A Reflection on the Choice of Further Prenatal Diagnosis.

Authors:  Sha Liu; Hongqian Liu; Jianlong Liu; Ting Bai; Xiaosha Jing; Tianyu Xia; Cechuan Deng; Yunyun Liu; Jing Cheng; Xiang Wei; Lingling Xing; Yuan Luo; Quanfang Zhou; Qian Zhu
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

4.  Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.

Authors:  Samantha Caldwell; Eyad Almasri; Lindsey Schmidt; Chen Xu; Brittany Dyr; Jenna Wardrop; Philip Cacheris
Journal:  Prenat Diagn       Date:  2021-03-08       Impact factor: 3.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.